These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33790851)

  • 1. Analysis of Thrombolysis Process for Acute Ischemic Stroke in Urban and Rural Hospitals in Nova Scotia Canada.
    Bulmer T; Volders D; Kamal N
    Front Neurol; 2021; 12():645228. PubMed ID: 33790851
    [No Abstract]   [Full Text] [Related]  

  • 2. Discrete-Event Simulation to Model the Thrombolysis Process for Acute Ischemic Stroke Patients at Urban and Rural Hospitals.
    Bulmer T; Volders D; Blake J; Kamal N
    Front Neurol; 2021; 12():746404. PubMed ID: 34777215
    [No Abstract]   [Full Text] [Related]  

  • 3. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
    Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
    JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke.
    Xian Y; Xu H; Lytle B; Blevins J; Peterson ED; Hernandez AF; Smith EE; Saver JL; Messé SR; Paulsen M; Suter RE; Reeves MJ; Jauch EC; Schwamm LH; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of tissue plasminogen activator for acute ischemic stroke in a rural Wisconsin hospital.
    Charipar R; Charipar E
    WMJ; 2008 Jul; 107(4):176-80. PubMed ID: 18702433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care.
    Paul CL; Ryan A; Rose S; Attia JR; Kerr E; Koller C; Levi CR
    Implement Sci; 2016 Apr; 11():51. PubMed ID: 27059183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre- and in-hospital delays in the use of thrombolytic therapy for patients with acute ischemic stroke in rural and urban Egypt.
    Nasreldein A; Walter S; Mohamed KO; Shehata GA; Ghali AA; Dahshan A; Faßbender K; Abd-Allah F
    Front Neurol; 2022; 13():1070523. PubMed ID: 36742046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke Thrombolysis in a Centralized and a Decentralized System (Helsinki and Telemedical Project for Integrative Stroke Care Network).
    Hubert GJ; Meretoja A; Audebert HJ; Tatlisumak T; Zeman F; Boy S; Haberl RL; Kaste M; Müller-Barna P
    Stroke; 2016 Dec; 47(12):2999-3004. PubMed ID: 27834751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive rural-urban disparity in acute stroke care.
    Gonzales S; Mullen MT; Skolarus L; Thibault DP; Udoeyo U; Willis AW
    Neurology; 2017 Jan; 88(5):441-448. PubMed ID: 28053009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Country-Wide Analysis of Systemic Factors Associated With Acute Ischemic Stroke Door to Needle Time.
    McVerry F; Hunter A; Dynan K; Matthews M; McCormick M; Wiggam I; Vahidassr D; McErlean F; Stevenson M; Hopkins E; McKee J; Kelly J; Kennedy F; McCarron MO
    Front Neurol; 2019; 10():676. PubMed ID: 31297081
    [No Abstract]   [Full Text] [Related]  

  • 11. The Role of Informed Consent for Thrombolysis in Acute Ischemic Stroke.
    Comer AR; Damush TM; Torke AM; Williams LS
    J Clin Ethics; 2019; 30(4):338-346. PubMed ID: 31851625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of Access to Critical Cerebral Emergency Support Services (ACCESS): a neuro-emergent telemedicine consultation program.
    Whetten J; van der Goes DN; Tran H; Moffett M; Semper C; Yonas H
    J Med Econ; 2018 Apr; 21(4):398-405. PubMed ID: 29316820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prehospital and hospital delays for stroke patients treated with thrombolysis: A retrospective study from mixed rural-urban area in Northern Finland.
    Varjoranta T; Raatiniemi L; Majamaa K; Martikainen M; Liisanantti JH
    Australas Emerg Care; 2019 Jun; 22(2):76-80. PubMed ID: 31042530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to administering intravenous tissue plasminogen activator (tPA) for acute ischemic stroke in the emergency department: A cross-sectional survey of stroke centers.
    Hargis M; Shah JN; Mazabob J; Rao CV; Suarez JI; Bershad EM
    Clin Neurol Neurosurg; 2015 Aug; 135():79-84. PubMed ID: 26047090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a 1-year quality-improvement process to reduce door-to-needle time in acute ischemic stroke with MRI screening.
    Sablot D; Gaillard N; Colas C; Smadja P; Gely C; Dutray A; Bonnec JM; Jurici S; Farouil G; Ferraro-Allou A; Jantac M; Allou T; Pujol C; Olivier N; Laverdure A; Fadat B; Mas J; Dumitrana A; Garcia Y; Touzani H; Perucho P; Moulin T; Richard C; Heroum C; Bouly S; Sagnes-Raffy C; Heve D
    Rev Neurol (Paris); 2017; 173(1-2):47-54. PubMed ID: 28131535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke.
    Xian Y; Smith EE; Zhao X; Peterson ED; Olson DM; Hernandez AF; Bhatt DL; Saver JL; Schwamm LH; Fonarow GC
    Stroke; 2014 May; 45(5):1387-95. PubMed ID: 24713527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving access to acute stroke therapies: a controlled trial of organised pre-hospital and emergency care.
    Quain DA; Parsons MW; Loudfoot AR; Spratt NJ; Evans MK; Russell ML; Royan AT; Moore AG; Miteff F; Hullick CJ; Attia J; McElduff P; Levi CR
    Med J Aust; 2008 Oct; 189(8):429-33. PubMed ID: 18928434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delays in door-to-needle time for acute ischemic stroke in the emergency department: A comprehensive stroke center experience.
    Mowla A; Doyle J; Lail NS; Rajabzadeh-Oghaz H; Deline C; Shirani P; Ching M; Crumlish A; Steck DA; Janicke D; Levy EI; Sawyer RN
    J Neurol Sci; 2017 May; 376():102-105. PubMed ID: 28431590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drill down analysis of door-to-needle time of acute ischemic stroke patients treated with intravenous tissue plasminogen activator.
    Schrock JW; Lum M
    Am J Emerg Med; 2014 Nov; 32(11):1330-3. PubMed ID: 25195044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Informed Consent Policy and Treatment Delays in Stroke Thrombolysis.
    Xu H; De Silva DA; Woon FP; Ong MEH; Matchar DB; Bettger JP; Laskowitz DT; Xian Y
    J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105551. PubMed ID: 33348248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.